DCAT Week '14, held March 10-14 in NYC, will address quality by design in a session titled, Quality by Design: Client, Contractor, and Regulatory Perspectives with Case Studies.
QbD’s emphasis on increased product and process understanding has raised the bar for pharmaceutical companies, contract manufacturers, and ingredient suppliers. Understanding the expectations and requirements under a QbD paradigm is crucial. Offering case studies from regulatory and company experience, the presenters will examine the benefits, opportunities, and challenges in implementing QbD in the production of APIs and drug products.
Pierre Boulas, Ph.D., Director of Analytical Development, Biogen Idec
Filipe Gaspar, Senior Director of Particle Engineering Services, Hovione
Dr. Anil Kane, Executive Director, Global Head of Formulation Sciences, Pharmaceutical Development, Patheon, Inc.
Nick Thomson, Director, Chemical Research and Development, Pfizer WRD
DCAT Week, organized annually by the Drug, Chemical & Associated Technologies Association, is one of the largest gatherings in the world for the pharmaceutical and related industries. Its unique model brings members from the entire spectrum of the pharmaceutical industry, including pharmaceutical innovation and production, chemical manufacturing, supply chain and logistics management, together for high-level meetings, strategy sessions, education programs and networking events.